Falu lasarett
- Address
- lock Available on a paid plan
Falu lasarett - Rheumatology Research Center
Falu lasarett is actively engaged in advancing the understanding and treatment of autoimmune rheumatic diseases. The center participates in sophisticated multi-center clinical trials that evaluate cutting-edge treatment strategies for patients with inflammatory joint conditions, contributing valuable data to the international rheumatology research community.
- Early rheumatoid arthritis treatment optimization and biologic therapy comparisons
- Remission achievement strategies using conventional and biologic disease-modifying agents
- Treatment de-escalation protocols for patients achieving therapeutic response
The center's research program emphasizes personalized treatment approaches in rheumatoid arthritis, including comparative effectiveness studies of active conventional therapy versus biologic treatments. Through participation in phase 4 randomized controlled trials, Falu lasarett contributes to establishing evidence-based guidelines for treatment de-escalation strategies, helping to optimize long-term disease management while potentially reducing medication burden in patients who achieve remission.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 20 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Karolinska Institutet2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Karolinska Institutet2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Falu lasarett
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy of Apixaban Versus Warfarin in Thrombus Resolution for Patients with Left Ventricular Thrombosis Post-Acute Myocardial Infarction | Karolinska Institutet | Phase III | Recruiting | Apr 2025 | — |
IMP list
lock Showing 1 of 20 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abatacept | 1 | Unknown | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.